In alignment with the Sustainable Development Goals (SDGs)—specifically Goal 3: Good Health and Well-being and Goal 4: Quality Education—and as part of the ongoing scientific efforts to enhance academic excellence, Assistant Lecturer Kadhim Adnan Ali, a faculty member at the College of Health and Medical Technologies at Al-Zahraa University for Women, has co-authored and published a significant scientific research paper titled:
“Modeling Drug-Organ Interactions and Optimizing Immunotherapy: A Quantitative Systems Pharmacology and Odronextamab Dynamics”
Key Highlights of the Research:
-Publication Venue: The study was published in a journal indexed within the National Library of Medicine (NLM) and categorized under Scopus databases, in collaboration with an international team of researchers.
- Core Focus: The research delves into modeling the intricate interactions between drugs and vital organs, optimizing the efficacy of immunotherapy through Quantitative Systems Pharmacology (QSP) methodologies, and examining the dynamics of the drug Odronextamab.
-Scientific Impact: This study directly contributes to advancing modern therapeutic strategies and improving clinical response rates, marking a progressive step toward sustainable healthcare solutions.
This scientific milestone underscores the commitment of the university’s faculty to fostering high-impact research and expanding global publication. Such achievements continue to strengthen the institution's academic journey and reflect its distinguished scientific standing on the international stage.
“Modeling Drug-Organ Interactions and Optimizing Immunotherapy: A Quantitative Systems Pharmacology and Odronextamab Dynamics”
Key Highlights of the Research:
-Publication Venue: The study was published in a journal indexed within the National Library of Medicine (NLM) and categorized under Scopus databases, in collaboration with an international team of researchers.
- Core Focus: The research delves into modeling the intricate interactions between drugs and vital organs, optimizing the efficacy of immunotherapy through Quantitative Systems Pharmacology (QSP) methodologies, and examining the dynamics of the drug Odronextamab.
-Scientific Impact: This study directly contributes to advancing modern therapeutic strategies and improving clinical response rates, marking a progressive step toward sustainable healthcare solutions.
This scientific milestone underscores the commitment of the university’s faculty to fostering high-impact research and expanding global publication. Such achievements continue to strengthen the institution's academic journey and reflect its distinguished scientific standing on the international stage.
Related Goals
Goal 3
Ensure healthy lives and promote well-being for all at all ages.
